1. Home
  2. BBIO vs ONB Comparison

BBIO vs ONB Comparison

Compare BBIO & ONB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BBIO
  • ONB
  • Stock Information
  • Founded
  • BBIO 2015
  • ONB 1834
  • Country
  • BBIO United States
  • ONB United States
  • Employees
  • BBIO N/A
  • ONB N/A
  • Industry
  • BBIO Biotechnology: Pharmaceutical Preparations
  • ONB Major Banks
  • Sector
  • BBIO Health Care
  • ONB Finance
  • Exchange
  • BBIO Nasdaq
  • ONB Nasdaq
  • Market Cap
  • BBIO 6.7B
  • ONB 7.9B
  • IPO Year
  • BBIO 2019
  • ONB N/A
  • Fundamental
  • Price
  • BBIO $34.25
  • ONB $20.86
  • Analyst Decision
  • BBIO Strong Buy
  • ONB Buy
  • Analyst Count
  • BBIO 12
  • ONB 9
  • Target Price
  • BBIO $57.09
  • ONB $26.11
  • AVG Volume (30 Days)
  • BBIO 2.9M
  • ONB 3.7M
  • Earning Date
  • BBIO 04-29-2025
  • ONB 07-22-2025
  • Dividend Yield
  • BBIO N/A
  • ONB 2.69%
  • EPS Growth
  • BBIO N/A
  • ONB N/A
  • EPS
  • BBIO N/A
  • ONB 1.72
  • Revenue
  • BBIO $127,415,000.00
  • ONB $1,795,802,000.00
  • Revenue This Year
  • BBIO $89.10
  • ONB $44.42
  • Revenue Next Year
  • BBIO $57.07
  • ONB $16.19
  • P/E Ratio
  • BBIO N/A
  • ONB $12.14
  • Revenue Growth
  • BBIO N/A
  • ONB 3.29
  • 52 Week Low
  • BBIO $21.62
  • ONB $15.60
  • 52 Week High
  • BBIO $39.54
  • ONB $24.49
  • Technical
  • Relative Strength Index (RSI)
  • BBIO 50.58
  • ONB 46.80
  • Support Level
  • BBIO $31.77
  • ONB $20.17
  • Resistance Level
  • BBIO $33.93
  • ONB $21.62
  • Average True Range (ATR)
  • BBIO 1.28
  • ONB 0.49
  • MACD
  • BBIO -0.09
  • ONB -0.13
  • Stochastic Oscillator
  • BBIO 57.14
  • ONB 27.27

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

About ONB Old National Bancorp

Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.

Share on Social Networks: